However, melanoma can bealso targeted with selected kinase activators; in fact, several anticancer agentsrequire the activation of the MAP kinase pathway mediated by JNK and p38 [29]; accordingly, our evidences confirm thatthe proapoptotic activity of MC3181 is dependent on JNK activation. Here, MAPK8 is linked to melanoma.